8-K/A
Current Report
C4 Therapeutics, Inc. Filed Acc 0001628280-24-042879
Executive or director change · Regulation FD disclosure
- Item 5.02 Departure or appointment of directors or officers
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading cccc-20241015.htm…